Overview

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Status:
Completed

Trial end date:
2010-07-09

Target enrollment:

Participant gender:

Summary

This study is being done to see if the blood pressure and metabolic effects of an approved drug nebivolol is comparable to that of another approved drug hydrochlorothiazide (HCTZ) and placebo in hypertensive patients.

Phase:

Phase 4

Details

Lead Sponsor:

Forest Laboratories

Treatments:

Hydrochlorothiazide
Lisinopril
Losartan
Nebivolol